<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied whether IV or subarachnoid (SA) <z:chebi fb="0" ids="6456">lidocaine</z:chebi> would influence the increase in extracellular <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> concentration in the hippocampal CA1 and the cerebral cortex during transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats by using the dialysis electrode method </plain></SENT>
<SENT sid="1" pm="."><plain>Fifty-four Sprague-Dawley rats were assigned to one of six treatment groups: IV <z:chebi fb="0" ids="6456">lidocaine</z:chebi> 5 mg/kg, IV <z:chebi fb="0" ids="6456">lidocaine</z:chebi> 10 mg/kg, IV 0.9% saline 0.5 mL/kg, SA <z:chebi fb="0" ids="6456">lidocaine</z:chebi> 5 mg/kg, SA <z:chebi fb="0" ids="6456">lidocaine</z:chebi> 10 mg/kg, and SA 0.9% saline 0.5 mL/kg (n = 9 in each group) </plain></SENT>
<SENT sid="2" pm="."><plain>Transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced by hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> and carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp>, 15 min after administration of <z:chebi fb="0" ids="6456">lidocaine</z:chebi> or saline </plain></SENT>
<SENT sid="3" pm="."><plain>The maximal values of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> concentration and the areas under <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> concentration curves in the CA1 were significantly less in the IV <z:chebi fb="0" ids="6456">lidocaine</z:chebi> 10 mg/kg group than the IV saline group, whereas those in the CA1 and the cortex were significantly less in the SA <z:chebi fb="0" ids="6456">lidocaine</z:chebi> 5 and 10 mg/kg groups than the SA saline group </plain></SENT>
<SENT sid="4" pm="."><plain>The accumulation of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> in the CA1 or the cortex during transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was attenuated by IV or SA <z:chebi fb="0" ids="6456">lidocaine</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>We conclude that the neuroprotective effect of <z:chebi fb="0" ids="6456">lidocaine</z:chebi> against transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> involves the suppression of the increase in extracellular <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> concentration </plain></SENT>
<SENT sid="6" pm="."><plain>IMPLICATIONS: IV or subarachnoid <z:chebi fb="0" ids="6456">lidocaine</z:chebi> was demonstrated to suppress <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> accumulation in the hippocampus and the cortex during transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats by using the dialysis electrode method </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="6456">Lidocaine</z:chebi> can have a neuroprotective effect through the suppression of the increase in extracellular <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> concentration </plain></SENT>
</text></document>